Canvas Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Buy
1,493
+59
+4% +$60.3K 0.25% 63
2026
Q1
$1.32M Buy
1,434
+2
+0.1% +$2.03K 0.22% 65
2025
Q4
$1.54M Buy
1,432
+52
+4% +$49.7K 0.26% 55
2025
Q3
$1.16M Sell
1,380
-71
-5% -$52.8K 0.21% 63
2025
Q2
$1.17M Sell
1,451
-28
-2% -$21.8K 0.23% 58
2025
Q1
$1.22M Sell
1,479
-33
-2% -$27.5K 0.31% 57
2024
Q4
$1.17M Buy
1,512
+96
+7% +$79.5K 0.29% 54
2024
Q3
$1.25M Buy
1,416
+569
+67% +$512K 0.35% 48
2024
Q2
$669K Buy
847
+8
+1% +$6.4K 0.21% 61
2024
Q1
$630K Buy
839
+252
+43% +$179K 0.21% 62
2023
Q4
$377K Sell
587
-9
-2% -$5.25K 0.14% 88
2023
Q3
$348K Sell
596
-29
-5% -$14.9K 0.14% 85
2023
Q2
$287K Sell
625
-13
-2% -$5.45K 0.11% 108
2023
Q1
$249K Buy
638
+11
+2% +$3.71K 0.1% 122
2022
Q4
$221K Buy
+627
New +$222K 0.09% 133

Other funds holding LLY

Canvas Wealth Advisors's LLY Position: Q2 2026 in Review

Canvas Wealth Advisors increased its Eli Lilly (LLY) stake by 4.1% in Q2 2026, buying an estimated $60.3K and bringing the position to 1,493 shares worth $1.79M. The position accounts for 0.25% of the portfolio, ranked #63.

Canvas Wealth Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Canvas Wealth Advisors held 1,493 shares of Eli Lilly worth $1.79M as of Q2 2026.
  • Canvas Wealth Advisors bought 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
  • Eli Lilly made up 0.25% of Canvas Wealth Advisors's portfolio in Q2 2026, its #63 holding.
  • Canvas Wealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.